Mark Zuckerberg and his wife, Priscilla Chan, plan to eradicate all human diseases by 2100 through their foundation, The Chan Zuckerberg In...

India's Securities and Exchange Board has banned seven companies, including Bharat Mohanlal Mehta, Impressive Trading and Lalita Bharat Meh...

The Mumbai bench of the National Company Law Tribunal (NCLT) has approved ₹256.4 crore resolution plan of Innova Captab for Sharon Bio Medi...

The goal for healthcare is to become more personal, predictive, preventative and participatory, and AI can make major contributions in thes...

According to the study, sieving through over 10 million coronavirus sequences, two PhD students at the Institute for Research in Biomedicin...

Some fund houses, including iLabs India Special Situations Fund, Edelweiss Alternative Assets Advisors, Capri Global Holdings, ACRE India, ...

US President Donald Trump has hinted that there would be consequences for China's alleged misinformation to the international community and...

A number of studies in the recent past suggested that Withanolides, Withaferin-A and Withanone, have multi-modal anticancer activities, acc...

The inspection was conducted during June 29, 2015 to July 7, 2015 at the Taloja plant, it added.

The MIIT has promised to improve the intellectual property management system to promote cooperation and profit sharing between centers.

The company has reported standalone losses in at least past four quarter. For the March quarter, it reported a widening of standalone profi...

Sharon Bio-Medicine said it has received the establishment inspection report (EIR) from the USFDA on closure of inspection of its Dehradun ...

Last month, USFDA had issued a warning letter to the firm for failing to pay generic drug user fee by its owner for three years starting 20...

One of the company's unit located at Taloja in Raigad district in Maharashtra has been inspected and audited by United States FDA.

The US regulator has issued a warning letter to Sharon Bio-medicine for failing to pay generic drug user fee by its owner for three years.

Drug firm Sharon Bio-Medicine today said its net profit rose by 23.65 per cent to Rs 11.97 crore for the quarter ended September 30, 2012 o...

Sharon Biomedicine was a dream come true for chartered accountant Mohan Kala, who had long wanted to make his fortune in the pharma sector.